Co‐infection of Klebsiella pneumonia, Cytomegalovirus, Aspergillus and Zygomycete in a patient with SARS‐CoV‐2. Issue 7 (11th July 2022)

• Record Type: Journal Article
• Authors: Pourabdollah Toutkaboni, Mihan; Hakamifard, Atousa; Abtahian, Zahra; Mirahmadian, Arefeh; Rahdar, Mohammad; Mokhber Dezfuli, Mojtaba; Tabarsi, Payam
• Is Part Of: Clinical case reports. Volume 10:Issue 7(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-07-11
• Subjects: aspergillosis -- CMV -- co‐infection -- COVID‐19 -- Klebsiella pneumoniae -- mixed infection -- mucormycosis; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.6033
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Co‐infection between severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and other pathogens has become a serious threat. There are the reports of fungal, bacterial, and viral co‐infections with SARS‐CoV‐2. We report the unusual case of concomitant aspergillosis, mucormycosis, cytomegalovirus pneumonia, and also klebsiella pneumoniae empyema as the complication of SARS‐CoV‐2. Abstract : Secondary infections or co‐infections are identified between SARS‐CoV‐2 and other pathogens. This entity has become another serious threat in treating the patients with SARS‐CoV‐2 infection, which should not be neglected.